136 related articles for article (PubMed ID: 15811255)
1. The PEACE study: limiting the role of angiotensin-converting enzyme inhibitors in stable coronary artery disease.
Lee RT
Curr Atheroscler Rep; 2005 May; 7(3):211-2. PubMed ID: 15811255
[No Abstract] [Full Text] [Related]
2. ACE inhibitors in patients with vascular disease: should the PEACE trial change medical practice?
Carey RM
Curr Hypertens Rep; 2005 Apr; 7(2):119-20. PubMed ID: 15748535
[No Abstract] [Full Text] [Related]
3. [Peace-study. Coronary heart disease: additive therapy with ACE-inhibitors?].
Böhm M
Internist (Berl); 2005 May; 46(5):592-4. PubMed ID: 15834542
[No Abstract] [Full Text] [Related]
4. Should patients with stable coronary artery disease be treated with ACE inhibitor therapy?
Gupta M; Lonn EM; Verma S
Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):124-5. PubMed ID: 16265450
[No Abstract] [Full Text] [Related]
5. Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design). Prevention of Events with Angiotensin-Converting Enzyme Inhibition.
Pfeffer MA; Domanski M; Rosenberg Y; Verter J; Geller N; Albert P; Hsia J; Braunwald E
Am J Cardiol; 1998 Aug; 82(3A):25H-30H. PubMed ID: 9719019
[TBL] [Abstract][Full Text] [Related]
6. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
[TBL] [Abstract][Full Text] [Related]
8. The effect of angiotensin-converting enzyme inhibitors on clinical outcomes in patients with ischemic cardiomyopathy and midrange ejection fraction: a post hoc subgroup analysis from the PEACE trial.
Alzahrani T; Tiu J; Panjrath G; Solomon A
Ther Adv Cardiovasc Dis; 2018 Dec; 12(12):351-359. PubMed ID: 30442080
[TBL] [Abstract][Full Text] [Related]
9. ACE inhibition in secondary prevention: are the results controversial?
Friedrich EB; Teo KK; Böhm M
Clin Res Cardiol; 2006 Feb; 95(2):61-7. PubMed ID: 16598512
[TBL] [Abstract][Full Text] [Related]
10. PEACE - an important yet neutral study of low-risk patients with CAD.
Cardiovasc J S Afr; 2005; 16(1):70-1. PubMed ID: 15778785
[No Abstract] [Full Text] [Related]
11. ACE inhibitors for patients with vascular disease without left ventricular dysfunction--may they rest in PEACE?
Pitt B
N Engl J Med; 2004 Nov; 351(20):2115-7. PubMed ID: 15531768
[No Abstract] [Full Text] [Related]
12. Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction.
Hansen JF; Tingsted L; Rasmussen V; Madsen JK; Jespersen CM
Am J Cardiol; 1996 Jun; 77(16):16D-21D. PubMed ID: 8677892
[TBL] [Abstract][Full Text] [Related]
13. Acute anti-ischemic effects of perindoprilat in men with coronary artery disease and their relation with left ventricular function.
Bartels GL; van den Heuvel FM; van Veldhuisen DJ; van der Ent M; Remme WJ
Am J Cardiol; 1999 Feb; 83(3):332-6. PubMed ID: 10072218
[TBL] [Abstract][Full Text] [Related]
14. Ongoing clinical trials of angiotensin-converting enzyme inhibitors for treatment of coronary artery disease in patients with preserved left ventricular function.
Pepine CJ
J Am Coll Cardiol; 1996 Apr; 27(5):1048-52. PubMed ID: 8609320
[TBL] [Abstract][Full Text] [Related]
15. New considerations relating to class effect with angiotensin-converting enzyme inhibitors--the PEACE study.
Sica DA
J Clin Hypertens (Greenwich); 2005 Mar; 7(3):188-93. PubMed ID: 15785163
[TBL] [Abstract][Full Text] [Related]
16. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
[TBL] [Abstract][Full Text] [Related]
17. ACE inhibition with ramipril improves left ventricular function at rest and post exercise in patients with stable ischaemic heart disease and preserved left ventricular systolic function.
Willenheimer R; Rydberg E; Oberg L; Juul-Möller S; Erhardt L
Eur Heart J; 1999 Nov; 20(22):1647-56. PubMed ID: 10543928
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
[TBL] [Abstract][Full Text] [Related]
19. Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE).
Al-Zakwani I; Sulaiman K; Al-Lawati JA; Alsheikh-Ali AA; Panduranga P; Al-Habib KF; Al Suwaidi J; Al-Mahmeed W; Al-Faleh H; Elasfar A; Al-Motarreb A; Ridha M; Bulbanat B; Al-Jarallah M; Bazargani N; Asaad N; Amin H
Curr Vasc Pharmacol; 2018; 16(6):596-602. PubMed ID: 28820057
[TBL] [Abstract][Full Text] [Related]
20. Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade.
van den Heuvel AF; Dunselman PH; Kingma T; Verhorst P; Boomsma F; van Gilst WH; van Veldhuisen DJ
J Am Coll Cardiol; 2001 Feb; 37(2):470-4. PubMed ID: 11216965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
